skip to main content

Haemodynamically unstable pulmonary embolism — MRCEM SBA MCQ

Instant feedback + full explanation. One question, done properly.

HardResuscitation and critical illnessHaemodynamically unstable pulmonary embolismMRCEM SBA

A 57-year-old woman presents with sudden dyspnoea and syncope. CTPA confirms large bilateral pulmonary emboli. Her blood pressure was 114/72 mmHg during imaging but has fallen to 78/44 mmHg and remains low after a cautious 250 mL crystalloid bolus. She is cool and clammy, with a lactate of 4.6 mmol/L. Bedside echocardiography shows a dilated right ventricle without pericardial effusion. She has no active bleeding, recent surgery or history of intracranial haemorrhage. Intravenous access and monitoring are established; she has not yet received anticoagulation. Which treatment and disposition plan is most appropriate?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Start continuous intravenous unfractionated heparin and arrange urgent systemic thrombolysis with critical care admission.

The CTPA establishes pulmonary embolism; the subsequent sustained hypotension and poor perfusion establish haemodynamic instability, rather than merely right-ventricular strain in a stable patient. With no stated major bleeding contraindication, she needs immediate senior-led resuscitation, continuous intravenous unfractionated heparin (UFH), urgent consideration of systemic thrombolysis, and critical care support. NICE specifically recommends continuous UFH for confirmed PE with haemodynamic instability and consideration of systemic thrombolysis. UFH can be interrupted and adjusted around reperfusion according to the local protocol. ([nice.org.uk](https://www.nice.org.uk/guidance/NG158/chapter/recommendations)) A offers reperfusion but substitutes low-molecular-weight heparin for the recommended UFH infusion in unstable PE. B supplies appropriate anticoagulation but leaves ongoing shock without an urgent reperfusion plan. D is a potential rescue approach when systemic thrombolysis is contraindicated or has failed, but neither condition is present. E treats this as PE suitable for oral anticoagulation without reperfusion; apixaban is an option for appropriate stable patients, not the initial plan for this patient in shock. Her earlier normal blood pressure must not determine treatment after clinical deterioration. ([bucksformulary.nhs.uk](https://www.bucksformulary.nhs.uk/docs/Guideline_9BFM.pdf?UID=94185328720231069357))

Reference: NICE NG158: Venous thromboembolic diseases — recommendations (Updated 2 August 2023) — https://www.nice.org.uk/guidance/ng158/chapter/Recommendations NICE NG158 evidence review D: pharmacological treatment (March 2020) — https://www.nice.org.uk/guidance/ng158/evidence/d-pharmacological-treatment-pdf-8710588337 Buckinghamshire Healthcare NHS Trust: Guideline for massive pulmonary embolus (Version 2.1; review date March 2023) — https://www.bucksformulary.nhs.uk/docs/Guideline_9BFM.pdf?UID=94185328720231069357